Clinical Trial: Detoxification and Treatment of Subjects With Medication Overuse Headache
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache
Brief Summary: The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.
Detailed Summary:
Sponsor: The New England Center for Headache, P.C.
Current Primary Outcome:
- Primary measure for the detoxification period
- Number of days with mild or no pain in the first two weeks of treatment
- Primary for the prevention of relapse
- Pain free days through day ninety
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Primary measure for the detoxification period
- Number of days without any headache in the first two weeks of treatment
- Primary for the prevention of relapse
- Headache frequency through day ninety
Original Secondary Outcome: Same as current
Information By: The New England Center for Headache, P.C.
Dates:
Date Received: February 6, 2007
Date Started: January 2007
Date Completion: February 2007
Last Updated: February 7, 2007
Last Verified: February 2007
